EDO Receives Contract for Navy Antennas.
This receive-only CA-3138-1 antenna was developed in cooperation with the U.S. Navy Radio Frequency and Antenna Branch at Space and Naval Warfare Systems Command, Calif. It is to be utilized on a number of Navy ships, including the Arleigh Burke (DDG 51) class destroyers.
"EDO continues to be a leader in developing state-of-the-art electronic self-defense systems," said Chief Executive Officer James M. Smith. "Our omni-directional antenna detects signals that are then processed by the ship's electronic surveillance and measurement system to determine if they are from hostile sources. Such situational awareness of the source and direction of a threat enables the commanding officer to quickly react with an appropriate defensive response."
EDO designs and manufactures a diverse range of products for defense, intelligence, and commercial markets, and provides related engineering and professional services. This includes supplying highly engineered antenna systems for communications, electronic warfare, navigation, radar, and wireless Local Area Networks for governments and commercial firms. EDO's antenna product line includes GPS, low RCS, spirals, horns, circular arrays and collinear arrays. For a complete list and descriptions, visit www.EDOcorp.com.
EDO's major product sectors include: Defense Electronics, Communications, Aircraft Armament Systems, Undersea Warfare, and Integrated Composite Structures. The company's advanced systems are at the core of the transformation to lighter, faster, and smarter defense capabilities.
With headquarters in New York, EDO Corporation employs 3,000 people worldwide. The company was founded in 1925 and had revenues of $648 million in 2005.
|Printer friendly Cite/link Email Feedback|
|Date:||May 2, 2006|
|Previous Article:||The Chemical Processing Industry Shows Strength with Sharp Average Project TIV Increase, an Industrial Info News Alert.|
|Next Article:||InSite Vision's AzaSite to Be Highlighted at ARVO Conference; Two Poster Presentations, Including a Second Anti-Infective Advisory Board Meeting.|